We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $4.58B
1-Year Est. Return 43.91%
This Fund
S&P 500
This Quarter Est. Return
+20.82%
1 Year Est. Return
+43.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.58B
AUM Growth
+$1.88B
Cap. Flow
+$1.03B
Cap. Flow %
22.6%
Top 10 Hldgs %
29.9%
Holding
435
New
231
Increased
47
Reduced
58
Closed
96

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$101M
2
JPM icon
JPMorgan Chase
JPM
+$79.2M
3
MCO icon
Moody's
MCO
+$58.8M
4
FITB
Fifth Third Bancorp
FITB
+$58.5M
5
LPLA icon
LPL Financial
LPLA
+$56M

Top Sells

Rank Stock Value
1
PNC icon
PNC Financial Services
PNC
+$68M
2
ACMR icon
ACM Research
ACMR
+$48.8M
3
CFG icon
Citizens Financial Group
CFG
+$47.1M
4
VSH icon
Vishay Intertechnology
VSH
+$46.3M
5
GS icon
Goldman Sachs
GS
+$44.7M

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.82%
2 Financials 20.39%
3 Healthcare 17.29%
4 Industrials 14.57%
5 Technology 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AS icon
76
Amer Sports
AS
$16.2B
$17.6M 0.39%
521,473
-177,040
-25% -$6.2M
XPO icon
77
XPO
XPO
$21.6B
$17.3M 0.38%
+84,513
New +$17.9M
JCI icon
78
Johnson Controls International
JCI
$87.8B
$17.3M 0.38%
118,276
-30,726
-21% -$4.34M
ONON icon
79
On Holding
ONON
$8.97B
$17.1M 0.37%
483,000
+170,000
+54% +$6.21M
KMI icon
80
Kinder Morgan
KMI
$69.9B
$17.1M 0.37%
+534,265
New +$17.2M
ABBV icon
81
AbbVie
ABBV
$443B
$16.9M 0.37%
+67,093
New +$14.4M
LPX icon
82
Louisiana-Pacific
LPX
$4.72B
$16.8M 0.37%
+213,511
New +$15.8M
JAZZ icon
83
Jazz Pharmaceuticals
JAZZ
$15.7B
$16.6M 0.36%
+68,792
New +$15.1M
EPAM icon
84
EPAM Systems
EPAM
$5.92B
$16.1M 0.35%
+202,856
New +$21.4M
ELVN icon
85
Enliven Therapeutics
ELVN
$4.21B
$15.9M 0.35%
312,560
+199,495
+176% +$8.47M
KNTK icon
86
Kinetik
KNTK
$4.39B
$15.1M 0.33%
311,859
+859
+0.3% +$41.1K
VRTX icon
87
Vertex Pharmaceuticals
VRTX
$132B
$15M 0.33%
30,279
+5,344
+21% +$2.37M
XLF icon
88
State Street Financial Select Sector SPDR ETF
XLF
$54B
$14.6M 0.32%
+272,485
New +$14.2M
GENI icon
89
Genius Sports
GENI
$1.88B
$14.4M 0.32%
2,379,279
-1,461,866
-38% -$7.57M
GWW icon
90
W.W. Grainger
GWW
$60.2B
$14.4M 0.31%
10,591
-676
-6% -$833K
BBIO icon
91
BridgeBio Pharma
BBIO
$14.9B
$14M 0.31%
+187,863
New +$13.2M
ARXS
92
Arxis Inc
ARXS
$22.6B
$13.8M 0.3%
+300,155
New +$11.7M
XYZ
93
Block Inc
XYZ
$47.7B
$13.5M 0.3%
+177,808
New +$12.5M
CTNM
94
Contineum Therapeutics
CTNM
$570M
$13.3M 0.29%
812,757
+80,669
+11% +$1.06M
HD icon
95
Home Depot
HD
$310B
$13.1M 0.29%
37,235
-8,765
-19% -$2.85M
TNGX icon
96
Tango Therapeutics
TNGX
$4.05B
$13M 0.28%
+414,902
New +$10.3M
WAY
97
Waystar Holding Corp
WAY
$4.58B
$13M 0.28%
+631,729
New +$13.3M
WH icon
98
Wyndham Hotels & Resorts
WH
$5.18B
$12.7M 0.28%
151,006
+71,306
+89% +$5.91M
ARES icon
99
Ares Management
ARES
$30.3B
$12.6M 0.27%
113,039
+109,964
+3,576% +$13.2M
HAE icon
100
Haemonetics
HAE
$4.69B
$12.3M 0.27%
+163,822
New +$10.5M
2 3
4
5 6

Similar funds

CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
MR
Munich Reinsurance Munich $4.57B AUM 28.39% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.59B AUM 9.32% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
AF
Avanza Fonder Stockholm, Sweden $4.59B AUM 41.03% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

Longaeva Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Longaeva Partners held 435 positions worth $4.58B, up 69% from $2.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Longaeva Partners deployed $1.03B of net new capital in Q2 2026, opening 231 new positions and adding to 47 existing holdings. Its largest new stake was SpaceX: 596,829 shares worth $102M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was ACM Research, an estimated $48.8M trimmed.

  • Longaeva Partners's largest Q2 2026 buy was SpaceX: 596,829 shares worth $102M.
  • Longaeva Partners added most to Mettler-Toledo International in Q2 2026, an estimated $39.4M increase.
  • Longaeva Partners's biggest Q2 2026 reduction was ACM Research, cutting an estimated $48.8M.
  • Longaeva Partners fully exited PNC Financial Services in Q2 2026, selling an estimated $68M.
  • Longaeva Partners's ten largest holdings make up 30% of its $4.58B portfolio in Q2 2026.
  • Longaeva Partners opened 231 new positions and closed 96 in Q2 2026.
  • Longaeva Partners's portfolio value rose 69% quarter-over-quarter to $4.58B.

Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.